If a CT scan is used as the reference imaging for the kidney, which test should be performed to confirm the findings?

Confirming CT Scan Findings of Kidney Lesions

For indeterminate renal masses found on CT scan, MRI abdomen without and with IV contrast is the most appropriate confirmatory test, offering superior specificity (68.1% vs 27.7%) while maintaining equivalent sensitivity to CT. 1

Primary Confirmatory Approach

When CT identifies an indeterminate renal mass, the diagnostic pathway depends on the specific clinical scenario:

MRI as First-Line Confirmation

MRI abdomen without and with IV contrast should be your go-to confirmatory test for most indeterminate renal masses. 1 The key advantages include:

• Higher specificity for diagnosing renal cell carcinoma (68.1% vs 27.7% for CT) with equivalent sensitivity (91.8% vs 94.5%) 1
• Superior detection of enhancement in masses with indeterminate enhancement on CT 1
• Better characterization of small lesions <1.5 cm due to higher specificity for small cysts and absence of pseudoenhancement artifact that plagues CT 1
• More sensitive contrast enhancement detection using the 15% enhancement threshold 1

When to Use Renal Mass Biopsy

Percutaneous biopsy should be strongly considered in these specific situations 1:

• Imaging features suggestive but not diagnostic of benign mass (e.g., fat-poor angiomyolipoma)
• Small incidental masses (T1a, <4 cm) where active surveillance is being considered
• Patients with limited life expectancy or significant comorbidities
• When one-third of biopsied masses prove benign, preventing unnecessary surgery 1

Important caveat: Nondiagnostic biopsy results (occurring in ~20% of small masses) cannot be considered evidence of benignity and may require repeat sampling. 1

Specific Clinical Scenarios

For Cystic Renal Masses

If CT suggests a complex cystic mass requiring Bosniak classification:

• MRI provides equivalent or superior characterization to CT 1
• Contrast-enhanced ultrasound (CEUS) is more sensitive than CT for characterizing cystic masses, upgrading 26% of lesions compared to CT 1
• CEUS shows 100% specificity for detecting malignancy in hypovascular small solid masses 1

For Hyperdense Renal Lesions

When CT shows hyperattenuating lesions that are indeterminate:

• Ultrasound can be useful for further characterization, with 98.1% of hyperechoic lesions ≥1 cm proving clinically insignificant 1
• MRI without contrast can differentiate hemorrhagic/proteinaceous cysts from RCC using T1 and T2 signal characteristics 1

When Contrast is Contraindicated

If both iodinated CT contrast and gadolinium-based MR contrast are contraindicated 1:

• Renal mass biopsy becomes the primary confirmatory test
• Noncontrast imaging provides limited characterization ability
• Only homogeneous masses <20 HU or >70 HU, or those with macroscopic fat, can be characterized as benign on noncontrast CT 1

Common Pitfalls to Avoid

1. Don't rely on CT alone for small lesions: Pseudoenhancement and partial volume averaging limit CT accuracy for masses ≤1.5 cm 1

2. Don't assume nondiagnostic biopsy means benign: Up to 20% of biopsies are nondiagnostic, especially in small masses, and 83.3% of repeat biopsies after initial nondiagnostic results prove diagnostic, with 80% being malignant 1

3. Don't skip MRI when CT enhancement is equivocal: MRI is specifically more sensitive for detecting enhancement in indeterminate cases 1

4. Consider CEUS in renal failure patients: Microbubbles aren't renally excreted, making CEUS extremely sensitive for identifying enhancing components when iodinated contrast is problematic 2